Congenital Disorders of Glycosylation (CDG): Update and Perspectives

Author(s): Renate Zeevaert, Els Schollen, Hubert Carchon, Gert Matthijs, Jaak Jaeken

Journal Name: Current Pediatric Reviews

Volume 2 , Issue 4 , 2006

Become EABM
Become Reviewer


Congenital Disorders of Glycosylation (CDG) are a rapidly growing family of genetic and mostly multisystem diseases caused by defects in the biosynthesis of the glycan moiety of glycoconjugates such as glycoproteins. Since the description of the first patients by Jaeken et al. in 1980, 23 defects have been identified in N- and O-protein glycosylation: 18 defects in N- or N- and O-glycosylation (12 glycan assembly defects: CDG-Ia to CDG-IL; 6 glycan processing defects: CDG-IIa to CDG-IIf) and 5 defects in O-glycosylation. There is a rapidly growing number of patients with a putative CDG in whom the known defects have been excluded (CDG-x). This review focuses on recent developments in the field including advances in the biochemical and molecular diagnosis of CDG and new features of known CDG. It also deals with the identification of new protein glycosylation disorders, of the first lipid glycosylation disorder, and of the emerging group of hyperglycosylation disorders. Finally, we speculate about future developments.

Keywords: CDG, COG, hyperglycosylation, lipid glycosylation, protein glycosylation

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2006
Page: [323 - 330]
Pages: 8
DOI: 10.2174/157339606778699699
Price: $65

Article Metrics

PDF: 2